More recently, WDR5 was found to physically interact with the proto-oncogene and transcription factor MYC to guide its chromatin binding and transcriptional activation, suggesting that WDR5 is a tractable target for MYC-driven cancers (Thomas et al., 2015a; Thomas et al., 2015b). The gene discussed is WDR5; the disease is cancer.